Enrolling by invitation NCT07213622
The Use of Smart Glasses for Saphenous Nerve Adductor Canal Block
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Smartglasses.
- Who it may be relevant to
- Registry conditions: Total Knee Arthroplasty. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The use of smart glasses for saphenous nerve adductor canal blocks compared to standard of care.
Interventions
- Procedure Smartglasses
Wearing smart glasses while performing a nerve block
Primary outcome measures
- Time from needle insertion to complete local anesthetic injection [Time frame: Until the end of the study]
Secondary outcome measures (1)
- Number of needle adjustments by user, ergonomics, head adjustments [Time frame: until the end of the study]
Eligibility criteria
Inclusion criteria
- patients 18 years or greater
- undergoing total knee arthroplasty
Exclusion criteria
- Patients with local infection at nerve block site
- BMI >40
- Patients who are at risk for local anesthesia systemic toxicity due to intraoperative local dose
- Patients with nerve damage to the femoral or saphenous nerve
- Documented history of mental or cognitive disabilities in EMR
- Non-English speaking patient
- Pregnant Women (self-reported)
- Prisoners
- Patients under the age of 18
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
United States · 1 center
- MetroHealth Hospital — Cleveland
Identifiers
NCT: NCT07213622 · STUDY00000465